Moreover, the RiskScore exhibited positive correlation with several immune checkpoint genes, including CD44, CD276, CD80, LGALS9, and CTLA4, demonstrating that HCC patients with higher RiskScore may be more possibly to experience immune evasion (Xu et al., 2020a). This evidence concerns the gene CD44 and hepatocellular carcinoma.